APA (7th ed.) Citation

Abdelkader, H., Abdel-Aleem, J. A., Mousa, H. S., Elgendy, M. O., Fatease, A. A., & Abou-Taleb, H. A. (2023). Captopril Polyvinyl Alcohol/Sodium Alginate/Gelatin-Based Oral Dispersible Films (ODFs) with Modified Release and Advanced Oral Bioavailability for the Treatment of Pediatric Hypertension. MDPI AG.

Chicago Style (17th ed.) Citation

Abdelkader, Hamdy, Jelan A. Abdel-Aleem, Heba Salah Mousa, Marwa O. Elgendy, Adel Al Fatease, and Heba A. Abou-Taleb. Captopril Polyvinyl Alcohol/Sodium Alginate/Gelatin-Based Oral Dispersible Films (ODFs) with Modified Release and Advanced Oral Bioavailability for the Treatment of Pediatric Hypertension. MDPI AG, 2023.

MLA (9th ed.) Citation

Abdelkader, Hamdy, et al. Captopril Polyvinyl Alcohol/Sodium Alginate/Gelatin-Based Oral Dispersible Films (ODFs) with Modified Release and Advanced Oral Bioavailability for the Treatment of Pediatric Hypertension. MDPI AG, 2023.